Iphase Bioscience

IPHASE Bioscience is an Australian company specializing in the development and manufacture of radiopharmaceuticals and molecular imaging agents, primarily for use in clinical trials and medical research. The company generates revenue by providing contract manufacturing, regulatory support, and supply chain solutions for pharmaceutical and biotechnology partners, particularly in the field of positron emission tomography (PET) imaging. Founded in 2007 and based in Melbourne, IPHASE has played a key role in supporting early-phase clinical development for both local and international clients. Notably, the company operates a TGA-licensed facility and has established collaborations with major hospitals and research institutions. Candidates should be aware that IPHASE is recognized for its technical expertise, regulatory compliance, and contributions to advancing precision medicine in Australia.

Recent Posts by Iphase Bioscience

1-7 of 7